New Edge Advisors, LLC Neurocrine Biosciences Inc Transaction History
New Edge Advisors, LLC
- $18.3 Billion
- Q2 2025
A detailed history of New Edge Advisors, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, New Edge Advisors, LLC holds 10,723 shares of NBIX stock, worth $1.47 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,723
Previous 7,630
40.54%
Holding current value
$1.47 Million
Previous $843,000
59.79%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding NBIX
# of Institutions
657Shares Held
101MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.94 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.34 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$761 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$610 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$422 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...